Buckingham Strategic Partners Lexicon Pharmaceuticals, Inc. Put Options Transaction History
Buckingham Strategic Partners
- $6.15 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LXRX
# of Institutions
134Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$85.8 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$6.02 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$5.17 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$2.32 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $119M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...